CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 461,075 | ||
| 2020-06-26 | Huang Jane CMO, Hematology | Option exercise | +2,079 | $160.40 | $333K | 2,079 |
| 2020-06-26 | Huang Jane CMO, Hematology | Sale | −679 | $200.27 | $136K | 1,400 |
| 2020-06-26 | Huang Jane CMO, Hematology | Sale | −700 | $200.29 | $140K | 700 |
| 2020-06-26 | Huang Jane CMO, Hematology | Sale | −700 | $200.30 | $140K | 0 |
| 2020-06-26 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −27,027 | 283,153 | ||
| 2020-06-24 | OYLER JOHN Chief Executive Officer | Sale | −4,741 | $186.11 | $882K | 9,640 |
| 2020-06-24 | OYLER JOHN Chief Executive Officer | Sale | −4,115 | $187.10 | $770K | 5,525 |
| 2020-06-24 | OYLER JOHN Chief Executive Officer | Sale | −3,800 | $188.20 | $715K | 1,725 |
| 2020-06-24 | OYLER JOHN Chief Executive Officer | Sale | −1,725 | $189.42 | $327K | 0 |
| 2020-06-23 | OYLER JOHN Chief Executive Officer | Sale | −690 | $184.56 | $127K | 28,761 |
| 2020-06-23 | OYLER JOHN Chief Executive Officer | Sale | −1,610 | $185.54 | $299K | 27,151 |
| 2020-06-23 | OYLER JOHN Chief Executive Officer | Sale | −4,922 | $186.63 | $919K | 22,229 |
| 2020-06-23 | OYLER JOHN Chief Executive Officer | Sale | −7,438 | $187.46 | $1.4M | 14,791 |
| 2020-06-23 | OYLER JOHN Chief Executive Officer | Sale | −410 | $188.43 | $77K | 14,381 |
| 2020-06-23 | Wang Xiaodong Director | Sale | −1,845 | $185.58 | $342K | 4,155 |
| 2020-06-23 | Wang Xiaodong Director | Sale | −3,455 | $186.62 | $645K | 700 |
| 2020-06-23 | Wang Xiaodong Director | Sale | −700 | $187.36 | $131K | 0 |
| 2020-06-22 | OYLER JOHN Chief Executive Officer | Sale | −900 | $179.58 | $162K | 38,832 |
| 2020-06-22 | OYLER JOHN Chief Executive Officer | Sale | −800 | $180.50 | $144K | 38,032 |
Page 92 of 99 · 1,972 trades